Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is the most frequent type of lung cancer accounting up to 80-85% of all lung cancer cases. Gemcitabine (Gem), a pyrimidine nucleoside antimetabolite, is widely used chemotherapy offering several months survival benefit in patients with NSCLC. The emergence of Gem r...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Eur J Pharmacol
Main Authors: Hatami, Elham, Nagesh, Prashanth K.B., Jaggi, Meena, Chauhan, Subhash C., Yallapu, Murali M.
Format: Artigo
Sprog:Inglês
Udgivet: 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7669739/
https://ncbi.nlm.nih.gov/pubmed/32805254
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173486
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker